Add BrightSurf on Google Email

WIN Consortium


WINTHER trial results

The WINTHER trial successfully matched personalized therapy to 35% of patients with advanced cancer, showing improved overall survival for those with a high degree of matching. The trial's strategy employed RNA expression testing to tailor treatment based on gene expression differences between tumors and normal tissues.

SourceWIN Consortium·JournalNature Medicine·DateApr 25, 2019